Cargando…
Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were per...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Association of Physical Chemists
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793461/ https://www.ncbi.nlm.nih.gov/pubmed/36578560 http://dx.doi.org/10.5599/admet.1465 |
_version_ | 1784859852063899648 |
---|---|
author | Kozlina, Filip Meštrović, Ivan Novak, Viktor Marjanović, Nikola Cetina-Čižmek, Biserka |
author_facet | Kozlina, Filip Meštrović, Ivan Novak, Viktor Marjanović, Nikola Cetina-Čižmek, Biserka |
author_sort | Kozlina, Filip |
collection | PubMed |
description | For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were performed using dexamethasone formulations containing castor oil as a solvent with the addition of cosolvents, 20 % (v/v) of isopropanol or Capryol(®) 90. Based on solubility testing results, castor oil was chosen as the best solvent amongst other vegetable oils, while a significant increase in solubility was obtained by adding either of the two cosolvents. Partitioning experiments were performed to ensure these formulations could achieve prolonged drug release. IVR testing was performed with model formulations and critical test parameters were varied in order to examine the method’s sensitivity. The developed method was sensitive to temperature and stirring rate, while coupling the USP II apparatus with a fiber optic UV-Vis spectrometer enabled complete automation. Moreover, due to the interference of excipients on fiber optic detection of dexamethasone during the release testing, derivative spectroscopy was successfully introduced for the elimination of the interference. The developed IVR method described herein could be useful in preformulation investigations and the early development of novel formulations. |
format | Online Article Text |
id | pubmed-9793461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Association of Physical Chemists |
record_format | MEDLINE/PubMed |
spelling | pubmed-97934612022-12-27 Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions Kozlina, Filip Meštrović, Ivan Novak, Viktor Marjanović, Nikola Cetina-Čižmek, Biserka ADMET DMPK Original Scientific Paper For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were performed using dexamethasone formulations containing castor oil as a solvent with the addition of cosolvents, 20 % (v/v) of isopropanol or Capryol(®) 90. Based on solubility testing results, castor oil was chosen as the best solvent amongst other vegetable oils, while a significant increase in solubility was obtained by adding either of the two cosolvents. Partitioning experiments were performed to ensure these formulations could achieve prolonged drug release. IVR testing was performed with model formulations and critical test parameters were varied in order to examine the method’s sensitivity. The developed method was sensitive to temperature and stirring rate, while coupling the USP II apparatus with a fiber optic UV-Vis spectrometer enabled complete automation. Moreover, due to the interference of excipients on fiber optic detection of dexamethasone during the release testing, derivative spectroscopy was successfully introduced for the elimination of the interference. The developed IVR method described herein could be useful in preformulation investigations and the early development of novel formulations. International Association of Physical Chemists 2022-10-11 /pmc/articles/PMC9793461/ /pubmed/36578560 http://dx.doi.org/10.5599/admet.1465 Text en Copyright © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Original Scientific Paper Kozlina, Filip Meštrović, Ivan Novak, Viktor Marjanović, Nikola Cetina-Čižmek, Biserka Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
title | Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
title_full | Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
title_fullStr | Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
title_full_unstemmed | Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
title_short | Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
title_sort | development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions |
topic | Original Scientific Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793461/ https://www.ncbi.nlm.nih.gov/pubmed/36578560 http://dx.doi.org/10.5599/admet.1465 |
work_keys_str_mv | AT kozlinafilip developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions AT mestrovicivan developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions AT novakviktor developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions AT marjanovicnikola developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions AT cetinacizmekbiserka developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions |